I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome
This is a prospective, open-label, randomized, two-arm clinical trial conducted to evaluate the safety and efficacy of romiplostim in comparison with eltrombopag in the treatment of thrombocytopenia in patients with Wiskott-Aldrich syndrome
platelet count
wiskott-aldrich syndrome
romiplostim
eltrombopag
ATM
- 0 views
- 16 Feb, 2024
- 1 location